Basel, Switzerland

Thomas Fessard



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Thomas Fessard: Innovator in Pharmaceutical Chemistry

Introduction

Thomas Fessard is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes for synthesizing complex chemical compounds. With a total of 2 patents, Fessard's work is instrumental in advancing medical treatments.

Latest Patents

Fessard's latest patents include the synthesis of 1,4-diazaspiro[5.5]undecan-3-one. This invention provides a process for preparing 1,4-diazaspiro[5.5]undecan-3-one and its analogues, which are useful in the preparation of pharmaceutical compounds. These compounds are particularly relevant for treating disorders involving abnormal cellular proliferation. The patent also details the chemical intermediates involved in the synthesis process.

Career Highlights

Throughout his career, Thomas Fessard has worked with prominent companies in the pharmaceutical industry. Notable among these are G1 Therapeutics, Inc. and Pharmacosmos Holding A/S. His experience in these organizations has allowed him to refine his expertise in drug development and chemical synthesis.

Collaborations

Fessard has collaborated with several professionals in his field, including Stephen E Schneider and Sagar Beldar. These collaborations have further enriched his work and contributed to the success of his inventions.

Conclusion

Thomas Fessard's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…